Lucie JOLLY

Scientist and Project Leader Biomarker Translational Research at Inotrem

Lucie Jolly's work experience includes the following:

1. Inotrem (February 2021 - Present): Scientist and Project Leader Biomarker Translational Research.

2. Inotrem (March 2018 - Present): Research engineer, PhD.

3. Inotrem (September 2014 - February 2018): PhD Student.

4. Inotrem SA (January 2014 - July 2014): Master 2 Intern.

5. Inserm UMR U116 DCAC (January 2013 - February 2013): Master 1 Intern.

Lucie JOLLY's education history begins with obtaining a Master's degree in Biosciences & Ingénierie de la Santé from Université de Lorraine. Following this, they pursued a Research Doctorate in the field of TREM-1, nouvel acteur de la cellule endothéliale et de la plaquette from the same university, completing it in 2018. In 2019, Lucie earned a DU CHIRURGIE EXPERIMENTALE GROS ANIMAUX ET PETITS ANIMAUX from Université de Lorraine. Additionally, they obtained a DU EXPÉRIMENTATION ANIMALE : NIVEAU 1 in 2015 from Université de Lorraine. No specific field of study is provided for this program.

Location

Sarralbe, France

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Inotrem

Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock.


Industries

Headquarters

Nancy, France

Employees

11-50

Links